Julie Parmentier

1.4k total citations · 1 hit paper
18 papers, 598 citations indexed

About

Julie Parmentier is a scholar working on Rheumatology, Surgery and Oncology. According to data from OpenAlex, Julie Parmentier has authored 18 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Julie Parmentier's work include Urticaria and Related Conditions (5 papers), Dermatology and Skin Diseases (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Julie Parmentier is often cited by papers focused on Urticaria and Related Conditions (5 papers), Dermatology and Skin Diseases (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Julie Parmentier collaborates with scholars based in United States, Germany and Japan. Julie Parmentier's co-authors include Neil Wishart, Heidi S. Camp, Matthew Rosebraugh, Robert J. Padley, Andrew J. Long, Lisa Olson, Michael Friedman, Jonathan S. George, M.A. Argiriadi and J W Voss and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Julie Parmentier

17 papers receiving 593 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

2018 276 citations Julie Parmentier, J W Voss et al. BMC Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Parmentier United States	8	185	165	136	124	120	18	598
Julie A. Di Paolo United States	9	148 0.8×	134 0.8×	168 1.2×	131 1.1×	24 0.2×	17	521
Maria Luisa Lombardi Italy	17	281 1.5×	110 0.7×	213 1.6×	212 1.7×	71 0.6×	38	832
Taher E. Taher United Kingdom	15	190 1.0×	92 0.6×	405 3.0×	39 0.3×	30 0.3×	23	669
Marc Azémar Germany	9	77 0.4×	150 0.9×	170 1.3×	142 1.1×	17 0.1×	15	492
P Hanke Germany	7	243 1.3×	45 0.3×	180 1.3×	91 0.7×	32 0.3×	23	628
Karen Berry United States	9	127 0.7×	175 1.1×	471 3.5×	24 0.2×	55 0.5×	12	755
Yujun Sheng China	15	252 1.4×	79 0.5×	437 3.2×	31 0.3×	77 0.6×	56	724
Philippe Wehrli Switzerland	5	358 1.9×	229 1.4×	281 2.1×	21 0.2×	240 2.0×	5	1.1k
Taichi Sekine Japan	15	203 1.1×	58 0.4×	196 1.4×	42 0.3×	20 0.2×	27	565
Chiara Angiolilli Netherlands	11	108 0.6×	78 0.5×	172 1.3×	25 0.2×	35 0.3×	16	512

Countries citing papers authored by Julie Parmentier

Since Specialization

Citations

This map shows the geographic impact of Julie Parmentier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Parmentier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Parmentier more than expected).

Fields of papers citing papers by Julie Parmentier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Parmentier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Parmentier. The network helps show where Julie Parmentier may publish in the future.

Co-authorship network of co-authors of Julie Parmentier

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Parmentier. A scholar is included among the top collaborators of Julie Parmentier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Parmentier. Julie Parmentier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Spiera, Robert, Valérie Devauchelle‐Pensec, Claire Owen, et al.. (2025). Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial. Arthritis & Rheumatology. 77(8). 1041–1051. 2 indexed citations

Buttgereit, Frank, Atul Singhal, Alan Kivitz, et al.. (2025). Efficacy and Safety of ABBV ‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial. Arthritis & Rheumatology. 77(12). 1673–1681.

Guttman‐Yassky, Emma, Alan D. Irvine, Patrick M. Brunner, et al.. (2023). The role of Janus kinase signaling in the pathology of atopic dermatitis. Journal of Allergy and Clinical Immunology. 152(6). 1394–1404. 47 indexed citations

Taylor, Peter C., Ernest Choy, Xenofon Baraliakos, et al.. (2023). Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases. Lara D. Veeken. 63(2). 298–308. 45 indexed citations

Mohamed, Mohamed‐Eslam F., et al.. (2023). Upadacitinib: Mechanism of action, clinical, and translational science. Clinical and Translational Science. 17(1). e13688–e13688. 61 indexed citations

McPherson, Michael J., Wendy Waegell, Shaughn H. Bryant, et al.. (2021). POS0365 ANTI-TNF GLUCOCORTICOID RECEPTOR MODULATOR ANTIBODY DRUG CONJUGATE FOR THE TREATMENT OF AUTOIMMUNE DISEASES. Annals of the Rheumatic Diseases. 80. 412–413. 7 indexed citations

Guttman‐Yassky, Emma, Ana B. Pavel, Jonathan I. Silverberg, et al.. (2020). Eosinophil count, serum CCL17/18/26 and immunoglobulin E levels in atopic dermatitis: upadacitinib phase 2 study analysis. World Allergy Organization Journal. 13(8). 100429–100429. 3 indexed citations

Song, Tao, Ana B. Pavel, Xiangyu Peng, et al.. (2019). 1024 Upadacitinib treatment of atopic dermatitis patients leads to reductions in epidermal hyperplasia and cellular infiltrates. Journal of Investigative Dermatology. 139(5). S177–S177. 3 indexed citations

Beck, Lisa A., Jonathan I. Silverberg, Kristie M. Grebe, et al.. (2019). Eosinophil Count and Serum Immunoglobulin E Levels in Atopic Dermatitis: Analysis of Upadacitinib Phase 2 Study Findings. Journal of Allergy and Clinical Immunology. 143(2). AB125–AB125. 5 indexed citations

10.

Parmentier, Julie, J W Voss, Candace Graff, et al.. (2018). In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). BMC Rheumatology. 2(1). 23–23. 276 indexed citations breakdown →

11.

Meyer, Christophe, et al.. (2017). Traitement d’un syndrome de Brodie unilatéral par contraction chirurgicale des maxillaires. Journal of Stomatology Oral and Maxillofacial Surgery. 118(1). 57–62. 1 indexed citations

12.

Ezell, Scott A., Michele Mayo, Teeru Bihani, et al.. (2014). Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma. Oncotarget. 5(13). 4990–5001. 41 indexed citations

13.

Vereecken, Carine, Marc Covents, Julie Parmentier, & Lea Maes. (2012). Test–retest reliability and agreement between children's and parents’ reports of a computerized food preferences tool. Public Health Nutrition. 16(1). 8–14. 7 indexed citations

14.

Zhang, Yue, Julie Parmentier, Zhongwu Lai, et al.. (2012). Spleen Tyrosine Kinase Inhibitor Fostamatinib Blocks B Cell Receptor Signaling and Reduces Viability of BCR Subtype Diffuse Large B Cell Lymphoma. Blood. 120(21). 3720–3720. 2 indexed citations

15.

Kadlub, Natacha, et al.. (2008). Traitement orthopédique des fractures extra-articulaires de la région condylienne de la mandibule : étude rétrospective de 39 fractures unifocales. Revue de Stomatologie et de Chirurgie Maxillo-faciale. 109(5). 301–305. 5 indexed citations

16.

Gozgit, Joseph M., Geraldine Bebernitz, Minwei Ye, et al.. (2008). Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2. Journal of Biological Chemistry. 283(47). 32334–32343. 77 indexed citations

17.

Parmentier, Julie, et al.. (1998). Multiple aneurysms of the splenic artery.. PubMed. 81(5). 244–244. 3 indexed citations

18.

Parmentier, Julie, et al.. (1997). Pancreatic cystosis in cystic fibrosis. Abdominal Imaging. 22(3). 313–314. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact